Legal & General Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,521
| Closed | -$49.9K | – | 3565 |
|
|
2024
Q1 | $49.9K | Sell |
5,521
-44
| -0.8% | -$398 | ﹤0.01% | 2778 |
|
|
2023
Q4 | $60.5K | Sell |
5,565
-159
| -3% | -$1.73K | ﹤0.01% | 2785 |
|
|
2023
Q3 | $46.1K | Sell |
5,724
-312
| -5% | -$2.51K | ﹤0.01% | 2874 |
|
|
2023
Q2 | $65.6K | Buy |
+6,036
| New | +$65.6K | ﹤0.01% | 2852 |
|
|
2022
Q2 | – | Sell |
-3,990
| Closed | -$37K | – | 3700 |
|
|
2022
Q1 | $37K | Buy |
3,990
+120
| +3% | +$1.11K | ﹤0.01% | 3069 |
|
|
2021
Q4 | $46K | Sell |
3,870
-34
| -0.9% | -$404 | ﹤0.01% | 3047 |
|
|
2021
Q3 | $44K | Hold |
3,904
| – | – | ﹤0.01% | 3016 |
|
|
2021
Q2 | $70K | Buy |
3,904
+755
| +24% | +$13.5K | ﹤0.01% | 2850 |
|
|
2021
Q1 | $49K | Sell |
3,149
-7,776
| -71% | -$121K | ﹤0.01% | 2819 |
|
|
2020
Q4 | $133K | Buy |
10,925
+7,949
| +267% | +$96.8K | ﹤0.01% | 2506 |
|
|
2020
Q3 | $38K | Sell |
2,976
-385
| -11% | -$4.92K | ﹤0.01% | 2782 |
|
|
2020
Q2 | $34K | Buy |
3,361
+95
| +3% | +$961 | ﹤0.01% | 2840 |
|
|
2020
Q1 | $27K | Buy |
3,266
+771
| +31% | +$6.37K | ﹤0.01% | 2807 |
|
|
2019
Q4 | $22K | Buy |
2,495
+481
| +24% | +$4.24K | ﹤0.01% | 3162 |
|
|
2019
Q3 | $12K | Hold |
2,014
| – | – | ﹤0.01% | 3246 |
|
|
2019
Q2 | $32K | Hold |
2,014
| – | – | ﹤0.01% | 2987 |
|
|
2019
Q1 | $34K | Buy |
2,014
+659
| +49% | +$11.1K | ﹤0.01% | 2875 |
|
|
2018
Q4 | $16K | Hold |
1,355
| – | – | ﹤0.01% | 3176 |
|
|
2018
Q3 | $54K | Hold |
1,355
| – | – | ﹤0.01% | 2736 |
|
|
2018
Q2 | $38K | Buy |
+1,355
| New | +$38K | ﹤0.01% | 2898 |
|